首页> 外文期刊>veterinary world >Evaluation of the efficacy of commercial live vaccines against the local Thai QX field strain for the protection of specific pathogen-free chicks
【24h】

Evaluation of the efficacy of commercial live vaccines against the local Thai QX field strain for the protection of specific pathogen-free chicks

机译:商业活疫苗对泰国当地 QX 田间菌株保护特定无病原体雏鸡的功效评估

获取原文
获取原文并翻译 | 示例

摘要

Background and Aim: The high prevalence of QX-like variant among Thai isolates poses a significant threat to poultry production. In this study, we evaluated the protective efficacy of commercially available heterologous infectious bronchitis virus (IBV) vaccines against the local Thai QX-like strain in specific -pathogen -free (SPF) chicks from Thailand. Materials and Methods: The experiment involved 100 SPF chicks divided into 4 arms. Arms I and II received the TAbic IB VAR (233A) and Ibird (1/96) vaccines, respectively, on day 1. After 10 days, both arms received the H120 vaccine. Arms III and IV were non -vaccinated positive and negative controls. Challenge infection was local Thai QX-like virus on birds of Arms I, II, and III, and negative control of Arm IV. Clinical signs of infectious bronchitis (IB) and IBV detection using reverse transcription polymerase chain reaction were assessed at 2, 4, and 6 days post -challenge (dpc). At 6 dpc, the birds were humanely euthanized for post-mortem examination with the ciliostasis test and histopathological analysis of the tracheas, lungs, and kidneys. Results: Virus shedding started at 4 dpc (33.3 positive) and reached 100 positivity at 6 dpc with obvious clinical respiratory symptoms in non -vaccinated -challenged birds. No detection of IBV in vaccinated -challenged arms. Ciliary activity scores were significantly lower in non -vaccinated -challenged birds at 23.64 (standard deviation SD +/- 1.74) and 96.50 (SD +/- 1.91) and 95.64 (SD +/- 1.77), respectively (p = 0.05) than in vaccinated -challenged birds. The most remarkable histopathological changes were observed in non -vaccinated -challenged birds, with moderately severe changes in the trachea, lungs, and kidneys. On the other hand, birds in vaccinated -challenged arms showed no significant changes. Conclusion: This study demonstrated the efficacy of TAbic IB VAR (233A) or Ibird (1/96) vaccine combined with a Massachusetts serotype vaccine (H120) against the local Thai QX-like strain in SPF chicks, contributing valuable insights to the selection of suitable commercially available vaccines to combat the prevalent local QX-like strains in Thailand.
机译:背景和目标:QX样变异株在泰国分离株中的高流行率对家禽生产构成重大威胁。在这项研究中,我们评估了市售异源传染性支气管炎病毒 (IBV) 疫苗对泰国特定无病原体 (SPF) 雏鸡中当地泰国 QX 样菌株的保护效果。材料和方法:实验涉及 100 只 SPF 雏鸡,分为 4 个臂。第 I 组和第 II 组在第 1 天分别接种了 TAbic IB VAR (233A) 和 Ibird (1/96) 疫苗。10 天后,两只手臂都接种了 H120 疫苗。第三组和第四组是未接种疫苗的阳性和阴性对照。挑战感染是I、II和III臂鸟类的局部泰国QX样病毒,IV臂的阴性对照。在攻击后 (DPC) 第 2、4 和 6 天评估感染性支气管炎 (IB) 的临床体征和使用逆转录聚合酶链反应检测 IBV。在 6 dpc 时,这些鸟类被人道地安乐死,进行尸检,进行纤毛矾滞试验和气管、肺和肾脏的组织病理学分析。结果:病毒脱落始于 4 dpc(33.3% 阳性),在 6 dpc 时达到 100% 阳性,在未接种疫苗的受攻击鸟类中具有明显的临床呼吸道症状。在接种疫苗的挑战组中未检测到 IBV。未接种疫苗的受挑战鸟类的睫状体活动评分显着降低,为 23.64(标准差 [SD] +/- 1.74)和 96.50(SD +/- 1。91) 和 95.64 (SD +/- 1.77) 分别比接种疫苗的受攻击鸟类 (p = 0.05) 多。在未接种疫苗的受感染鸟类中观察到最显着的组织病理学变化,气管、肺和肾脏出现中度严重变化。另一方面,接种疫苗的鸟类没有表现出显着变化。结论: 本研究证明了TAbic IB VAR(233A)或Ibird(1/96)疫苗联合马萨诸塞州血清型疫苗(H120)对SPF雏鸡当地泰国QX样菌株的疗效,为选择合适的市售疫苗对抗泰国流行的本地QX样菌株提供了宝贵的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号